New Strategy to Treat Flu Virus Symptoms: Inhibiting OX40 Molecule

The video discusses the influenza A virus and a new treatment strategy developed by British scientists at Imperial College, London. This strategy involves inhibiting the OX40 molecule to alleviate flu symptoms without affecting virus clearance. Initial research on mice has shown promising results, and human trials are forthcoming. The research may also have implications for treating SARS and other conditions linked to excessive immune responses.

How might the new treatment method for flu be relevant to the SARS virus?

What potential implications does the work with OX40 have for other conditions?